SUPER VIABEST Tablets SUPER VIABEST is a fixed-dose combination therapy containing Sildenafil Citrate and Dapoxetine Hydrochloride designed to simultaneously manage erectile dysfunction and premature ejaculation in adult males. Sildenafil acts as a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting PDE5, it prevents the degradation of cGMP in the corpus cavernosum, enhancing nitric oxide (NO)-mediated smooth muscle relaxation and promoting increased penile blood flow to achieve and sustain an erection. Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that inhibits neuronal reuptake of serotonin (5-HT), increasing neurotransmitter activity within central and spinal ejaculatory pathways to delay the ejaculatory reflex and extend intravaginal ejaculatory latency time (IELT). SUPER VIABEST is indicated for the treatment of erectile dysfunction co-occurring with premature ejaculation in adult men aged 18 to 64 years.